2,586
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Unprecedented outbreak of respiratory syncytial virus in Taiwan associated with ON1 variant emergence between 2010 and 2020

, , , , , , , , , , , , , , ORCID Icon, & show all
Pages 1000-1009 | Received 04 Oct 2021, Accepted 13 Mar 2022, Published online: 31 Mar 2022

References

  • Lee HH, Lin SH. Effects of COVID-19 prevention measures on other common infections, Taiwan. Emerg Infect Dis. 2020;26(10):2509–2511.
  • Rima B, Collins P, Easton A, et al. ICTV virus taxonomy profile: pneumoviridae. J Gen Virol. 2017;98(12):2912–2913.
  • Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–598.
  • Carroll KN, Wu P, Gebretsadik T, et al. Season of infant bronchiolitis and estimates of subsequent risk and burden of early childhood asthma. J Allergy Clin Immunol. 2009;123(4):964–966.
  • Shi T, McAllister DA, O'Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946–958.
  • McLellan JS, Ray WC, Peeples ME. Structure and function of respiratory syncytial virus surface glycoproteins. Curr Top Microbiol Immunol. 2013;372:83–104.
  • Schobel SA, Stucker KM, Moore ML, et al. Respiratory syncytial virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene. Sci Rep. 2016;6:26311.
  • Eshaghi A, Duvvuri VR, Lai R, et al. Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication. PLoS One. 2012;7(3):e32807.
  • Midulla F, Di Mattia G, Nenna R, et al. Novel variants of respiratory syncytial virus A ON1 associated with increased clinical severity of bronchiolitis. J Infect Dis. 2020;222(1):102–110.
  • Otieno JR, Kamau EM, Agoti CN, et al. Spread and evolution of respiratory syncytial virus A genotype ON1, coastal Kenya, 2010-2015. Emerg Infect Dis. 2017;23(2):264–271.
  • Yoshihara K, Le MN, Okamoto M, et al. Association of RSV-A ON1 genotype with increased pediatric acute lower respiratory tract infection in Vietnam. Sci Rep. 2016;6:27856.
  • Chi H, Hsiao KL, Weng LC, et al. Persistence and continuous evolution of the human respiratory syncytial virus in northern Taiwan for two decades. Sci Rep. 2019;9(1):4704.
  • Lam TT, Zhu H, Guan Y, et al. Genomic analysis of the emergence, evolution, and spread of human respiratory RNA viruses. Annu Rev Genom Hum Genet. 2016;17:193–218.
  • Panayiotou C, Richter J, Koliou M, et al. Epidemiology of respiratory syncytial virus in children in Cyprus during three consecutive winter seasons (2010–2013): age distribution, seasonality and association between prevalent genotypes and disease severity. Epidemiol Infect. 2014;142(11):2406–2411.
  • Midulla F, Nenna R, Scagnolari C, et al. How respiratory syncytial virus genotypes influence the clinical course in infants hospitalized for bronchiolitis. J Infect Dis. 2019;219(4):526–534.
  • Comas-Garcia A, Noyola DE, Cadena-Mota S, et al. Respiratory syncytial virus-A ON1 genotype emergence in central Mexico in 2009 and evidence of multiple duplication events. J Infect Dis. 2018;217(7):1089–1098.
  • Vos LM, Oosterheert JJ, Kuil SD, et al. High epidemic burden of RSV disease coinciding with genetic alterations causing amino acid substitutions in the RSV G-protein during the 2016/2017 season in The Netherlands. J Clin Virol. 2019;112:20–26.
  • Vigerust DJ, Shepherd VL. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 2007;15(5):211–218.
  • Ruckwardt TJ, Morabito KM, Graham BS. Immunological lessons from respiratory syncytial virus vaccine development. Immunity. 2019;51(3):429–442.
  • Adams O, Bonzel L, Kovacevic A, et al. Palivizumab-resistant human respiratory syncytial virus infection in infancy. Clin Infect Dis. 2010;51(2):185–188.
  • Tabor DE, Fernandes F, Langedijk AC, et al. Global molecular epidemiology of respiratory syncytial virus from the 2017–2018 INFORM-RSV study. J Clin Microbiol. 2020;59(1):e01828–e01820.
  • Bin L, Liu H, Tabor DE, et al. Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015–17. Sci Rep. 2019;9(1):3898.
  • Taiwan Centers for Disease Control. Taiwan National Infectious Disease Statistics System. https://nidss.cdc.gov.tw (accessed May 2021).
  • Jo WK, Schadenhofer A, Habierski A, et al. Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants. Proc Natl Acad Sci USA. 2021;118(14):e2026558118.
  • Ujiie M, Tsuzuki S, Nakamoto T, et al. Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan. Emerg Infect Dis; 27(11):2969–2970.
  • John-Sebastian E, Sikazwe C, Xie R, et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. medRxiv.
  • Weinberger Opek M, Yeshayahu Y, Glatman-Freedman A, et al. Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-physical distancing measures, Ashdod, Israel, 2021. Euro Surveill. 2021;26(29):2100706.
  • Wu A, Mihaylova VT, Landry ML, et al. Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study. Lancet Microbe. 2020;1(6):e254–e262.